Chicago Equity Partners’s Genomic Health, Inc. GHDX Stock Holding History

Chicago Equity Partners’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,840	Closed	-$260K	–	1009
2019 Q3	$260K	Sell	3,840 -140	-4%	-$9.62K	0.01%	803
2019 Q2	$232K	Sell	3,980 -415	-9%	-$24.6K	0.01%	843
2019 Q1	$308K	Sell	4,395 -18,705	-81%	-$1.39M	0.01%	759
2018 Q4	$1.49M	Hold	23,100	–	–	0.06%	399
2018 Q3	$1.62M	Buy	+23,100	New	+$1.35M	0.05%	428

Chicago Equity Partners's GHDX Position: Q4 2019 in Review

Chicago Equity Partners sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 3,840 shares — an estimated $260K sold.

Chicago Equity Partners first reported a position in GHDX in Q3 2018 and held it in 5 quarters. The position peaked at $1.62M in Q3 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Chicago Equity Partners reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Chicago Equity Partners sold 3,840 Genomic Health, Inc. shares in Q4 2019, an estimated $260K.
Chicago Equity Partners first reported a position in Genomic Health, Inc. in Q3 2018 and held it in 5 quarters.
Chicago Equity Partners's Genomic Health, Inc. position peaked at $1.62M in Q3 2018.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Chicago Equity Partners's 13F filing for Q4 2019, filed 10 Feb 2020.